Cargando…

Assessment of Bone Health Education in US Multiple Myeloma and Solid Tumor Patients at Risk for Skeletal-Related Events

PURPOSE: Cancer patients with bone metastasis (BM) from solid tumors or multiple myeloma (MM) have an increased risk of painful skeletal-related events (SREs), which can decrease quality of life and increase mortality. Bone targeting agents (BTAs) can help delay or prevent SREs; however, a significa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flora, Darcy R, Carlson, Katherine B, Fuehrer, David C, Cadieux, Benoit, Boike, Guy, Schenfeld, Jennifer, Lowe, Kimberly A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079256/ https://www.ncbi.nlm.nih.gov/pubmed/33935518 http://dx.doi.org/10.2147/CMAR.S300063

Ejemplares similares

Assessment of Bone Health Awareness and Education in Breast Cancer Patients with Bone Metastasis in the USA
por: Flora, Darcy R., et al.
Publicado: (2023)

Discharge status and post-discharge healthcare costs after skeletal-related event hospitalizations among medicare patients with bone metastatic solid tumors or multiple myeloma
por: Li, Suying, et al.
Publicado: (2020)

Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach
por: Jacobson, Dionna, et al.
Publicado: (2022)

Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval
por: Cadieux, Benoit, et al.
Publicado: (2022)

Prevention Of Skeletal Related Events In Multiple Myeloma: Focus On The RANK-L Pathway In The Treatment Of Multiple Myeloma
por: Parrondo, Ricardo D, et al.
Publicado: (2019)

The importance of retaining physical functions to prevent skeletal‐related events in multiple myeloma patients with bone disease
por: Miki, Hirokazu, et al.
Publicado: (2022)

What is the relationship between bone turnover markers and skeletal-related events in patients with bone metastases from solid tumors and in patients with multiple myeloma? A systematic review and meta-regression analysis
por: Jiang, Zefei, et al.
Publicado: (2020)

Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours
por: Durán, I., et al.
Publicado: (2013)

Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis
por: Schenfeld, Jennifer, et al.
Publicado: (2017)

Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma
por: Zhou, Jifang, et al.
Publicado: (2021)

Bone metastases and skeletal-related events from neuroendocrine tumors
por: Van Loon, Katherine, et al.
Publicado: (2015)

Ibandronate to treat skeletal-related events and bone pain in metastatic bone disease or multiple myeloma: a meta-analysis of randomised clinical trials
por: Geng, Chun-Jing, et al.
Publicado: (2015)

Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study
por: Hong, Soojung, et al.
Publicado: (2020)

Multiple myeloma: imaging evaluation of skeletal disease
por: Sexton, Carlton, et al.
Publicado: (2013)

Computed tomography–based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myeloma
por: Takahashi, Maria E.S., et al.
Publicado: (2020)

Incidence of Skeletal-Related Events in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US
por: Kawai, Alison Tse, et al.
Publicado: (2019)

Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma
por: Najjar, Mimi, et al.
Publicado: (2023)

Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data
por: Kim, Christopher, et al.
Publicado: (2018)

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events
por: Smith, M. R., et al.
Publicado: (2015)

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events
Publicado: (2015)

Bone Health Outcomes from the International, Multicenter, Randomized, Phase 3, Placebo-Controlled D-CARE Study Assessing Adjuvant Denosumab in Early Breast Cancer
por: Coleman, Robert, et al.
Publicado: (2021)

Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?
por: Annibali, O., et al.
Publicado: (2020)

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
por: Polascik, Thomas J
Publicado: (2009)

Health state utilities for skeletal-related events secondary to bone metastases
por: Matza, Louis S., et al.
Publicado: (2013)

B03: SKELETAL-RELATED EVENTS AND ABNORMAL MRI PATTERN AT DIAGNOSIS ARE ASSOCIATED WITH INFERIOR OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
por: Terpos, Evangelos, et al.
Publicado: (2022)

Extra-skeletal plasmablastic myeloma presenting as palatal growth – An unusual entity
por: Kumar, Sanjay, et al.
Publicado: (2017)

Circulating microRNAs Correlate with Multiple Myeloma and Skeletal Osteolytic Lesions
por: Moura, Sara Reis, et al.
Publicado: (2021)

Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors
por: Brown-Glaberman, Ursa, et al.
Publicado: (2012)

A retrospective cohort study to evaluate the development of comorbidities, including psychiatric comorbidities, among a pediatric psoriasis population
por: Paller, Amy S., et al.
Publicado: (2019)

An Early Myeloma Bone Disease Model in Skeletally Mature Mice as a Platform for Biomaterial Characterization of the Extracellular Matrix
por: Ziouti, Fani, et al.
Publicado: (2020)

Event dependence in U.S. executions
por: Baumgartner, Frank R., et al.
Publicado: (2018)

Transient Hypophosphatemia: A Dangerous Event in Multiple Myeloma
por: Jeffs, Paula, et al.
Publicado: (2021)

Skeletal-Related Events After Surgery With or Without Radiotherapy for Bone Metastases to Weight-Bearing Bones
por: Lanier, Claire M, et al.
Publicado: (2022)

Weight-Based Bisphosphonate Administration for Multiple Myeloma Patients and the Risks of Skeletal Complications
por: Bahk, Ji Hoon, et al.
Publicado: (2023)

Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related events
por: Hardtstock, Fränce, et al.
Publicado: (2021)

Relapsed Extramedullary Multiple Myeloma Presenting as Bilateral Solid Perirenal Masses
por: Rau, Thomas, et al.
Publicado: (2015)

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
por: Ludwig, Heinz, et al.
Publicado: (2018)

The Role of the Molecular Clock in Skeletal Muscle and What It Is Teaching Us About Muscle-Bone Crosstalk
por: Riley, Lance A., et al.
Publicado: (2017)

Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 Patients
por: Kanellias, Nikolaos, et al.
Publicado: (2022)

Skeletal Muscle Mitochondria and Aging: A Review
por: Peterson, Courtney M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_db0jp006fdme6ff7h5t46dsngi